|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C12N 5/20 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Patento numeris | 2068921 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07868508.8 |
| Europos patento paraiškos padavimo data | 2007-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-06-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/081879 |
| Data | 2007-10-19 |
| (87) | Numeris | WO 2008/060813 |
| Data | 2008-05-22 |
| (30) | Numeris | Data | Šalis |
| 852884 P | 2006-10-19 | US |
| (72) |
NASH, Andrew Donald, AU
BACA, Manuel, US
FABRI, Louis Jerry, AU
ZALLER, Dennis, US
STROHL, William R., US
AN, Zhiqiang, US
|
| (73) |
CSL Limited,
45 Poplar Road, Parkville VIC 3052,
AU
|
| (54) | HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1 |
| HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1 |